Related Experiment Video
Updated: Jun 25, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Providing patients with information on pharmacogenetic testing.
Nigel Fleeman1, Rumona Dickson
1Liverpool Reviews and Implementation Group, University of Liverpool. nigel.fleeman@liverpool.ac.uk
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|March 3, 2009
Summary
This article discusses crucial considerations before recommending pharmacogenetic testing. These tests can predict how a patient might respond to specific medications, aiding personalized medicine.
Area of Science:
- Pharmacology
- Genetics
- Clinical Medicine
Background:
- Pharmacogenetic testing offers potential for personalized drug therapy.
- Predicting drug response can optimize treatment efficacy and minimize adverse effects.
- Several factors influence the successful implementation of pharmacogenetic tests.
Purpose of the Study:
- To identify and outline key considerations for recommending pharmacogenetic tests.
- To provide guidance for clinicians on the appropriate use of pharmacogenetic information.
- To highlight the importance of evidence-based decision-making in pharmacogenetic testing.
Main Methods:
- Literature review of current pharmacogenetic guidelines and research.
- Analysis of clinical utility and validity of various pharmacogenetic assays.
- Discussion of ethical, legal, and social implications (ELSI).
Main Results:
- Key issues include test availability, cost-effectiveness, and clinical validity.
- Interpretation of results requires specialized knowledge and consideration of patient-specific factors.
- Integration into clinical workflows presents practical challenges.
Conclusions:
- Pharmacogenetic testing holds promise but requires careful consideration of multiple factors.
- Evidence-based recommendations are essential for responsible clinical adoption.
- Further research and education are needed to maximize the benefits of pharmacogenetics.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...